Cargando…

Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults

INTRODUCTION: Tenofovir disoproxil fumarate (TDF) is widely recommended for treatment of chronic hepatitis B virus (HBV) infection because it is safe, affordable and has a high genetic barrier to resistance. TDF resistance associated mutations (RAMs) have been reported, but data are limited, particu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mokaya, Jolynne, Maponga, Tongai G, McNaughton, Anna L, Van Schalkwyk, Marije, Hugo, Susan, Singer, Joshua B, Sreenu, Vattipally B, Bonsall, David, de Cesare, Mariateresa, Andersson, Monique, Gabriel, Shiraaz, Taljaard, Jantje, Barnes, Eleanor, Preiser, Wolfgang, Van Rensburg, Christo, Matthews, Philippa C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408481/ https://www.ncbi.nlm.nih.gov/pubmed/32663786 http://dx.doi.org/10.1016/j.jcv.2020.104548

Ejemplares similares

Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort
por: Maponga, Tongai G., et al.
Publicado: (2020)

A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review
por: Mokaya, Jolynne, et al.
Publicado: (2018)

Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South Africa
por: Mofokeng, Nombuyiselo, et al.
Publicado: (2023)

HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa
por: Maponga, Tongai Gibson, et al.
Publicado: (2018)

Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms
por: Mokaya, Jolynne, et al.
Publicado: (2020)

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)
por: McNaughton, Anna L., et al.
Publicado: (2019)

A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action
por: Mokaya, Jolynne, et al.
Publicado: (2018)

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
por: Mokaya, Jolynne, et al.
Publicado: (2019)

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
por: Wang, Tingyan, et al.
Publicado: (2021)

Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis
por: McNaughton, Anna L., et al.
Publicado: (2020)

So far, no novel SARS-CoV-2 variants from Beijing—and hopefully better scientific cooperation going forward
por: Preiser, Wolfgang, et al.
Publicado: (2023)

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
por: Mokaya, Jolynne, et al.
Publicado: (2021)

No point in travel bans if countries with poor surveillance are ignored
por: Preiser, Wolfgang, et al.
Publicado: (2022)

A Study of Knowledge, Experience, and Beliefs About Hepatitis B Virus (HBV) Infection in South Western Uganda
por: Mugisha, Joseph, et al.
Publicado: (2019)

Endemic HBV among hospital in-patients in Bangladesh, including evidence of occult infection
por: Chowdhury, Fazle Rabbi, et al.
Publicado: (2021)

Prevalence of chronic HBV infection in pregnant woman attending antenatal care in a tertiary hospital in Mwanza, Tanzania: a cross-sectional study
por: Geffert, Karin, et al.
Publicado: (2020)

Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South Africa
por: Downs, Louise O., et al.
Publicado: (2020)

Hepatitis B virus infection as a neglected tropical disease
por: O’Hara, Geraldine A., et al.
Publicado: (2017)

Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors
por: O'Hara, Geraldine, et al.
Publicado: (2020)

The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda
por: Martyn, Emily, et al.
Publicado: (2023)

Is hepatitis B birth dose vaccine needed in Africa?
por: Tamandjou, Cynthia Raissa, et al.
Publicado: (2017)

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
por: Pley, Caitlin M, et al.
Publicado: (2021)

Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences
por: McNaughton, Anna L., et al.
Publicado: (2020)

Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection
por: Downs, Louise O., et al.
Publicado: (2021)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
por: Bihl, Florian, et al.
Publicado: (2015)

Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review
por: Dakurah, Ottovon Bismark, et al.
Publicado: (2021)

Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis
por: Campbell, Cori, et al.
Publicado: (2020)

Overview of influenza virus infections in Kenya: past, present and future
por: Matheka, Duncan Mwangangi, et al.
Publicado: (2013)

3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China
por: Hou, Jinlin, et al.
Publicado: (2021)

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis
por: Price, Huw, et al.
Publicado: (2013)

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
por: Yang, Young-Mo, et al.
Publicado: (2017)

Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy
por: Zeng, Jianyong, et al.
Publicado: (2019)

Insights From Deep Sequencing of the HBV Genome—Unique, Tiny, and Misunderstood
por: McNaughton, Anna L., et al.
Publicado: (2019)

What Constitutes Protective Immunity Following Yellow Fever Vaccination?
por: Mokaya, Jolynne, et al.
Publicado: (2021)

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV
por: Pan, Calvin Q., et al.
Publicado: (2021)

Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV
por: Puri, Ashana, et al.
Publicado: (2019)

Tenofovir-associated kidney disease in Africans: a systematic review
por: Mtisi, Takudzwa J., et al.
Publicado: (2019)

An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression
por: Das, Srijanee, et al.
Publicado: (2022)

Tenofovir vs Entecavir Among Patients With HBV-Related HCC After Resection
por: Li, Pengpeng, et al.
Publicado: (2023)

Hepatitis B Virus: Infection, liver disease, carcinogen or syndemic threat? Remodelling the clinical and public health response
por: Matthews, Philippa C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_igrq97hkk2asuoumrga0jd92t7